Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 1
1970 1
1974 6
1975 12
1976 31
1977 23
1978 24
1979 28
1980 22
1981 32
1982 23
1983 23
1984 23
1985 33
1986 38
1987 46
1988 46
1989 42
1990 59
1991 84
1992 108
1993 135
1994 138
1995 179
1996 188
1997 179
1998 198
1999 182
2000 235
2001 214
2002 235
2003 199
2004 225
2005 271
2006 243
2007 281
2008 264
2009 271
2010 323
2011 279
2012 311
2013 258
2014 323
2015 285
2016 287
2017 261
2018 332
2019 215
2020 13
Text availability
Article attribute
Article type
Publication date

Search Results

6,711 results
Results by year
Filters applied: . Clear all
Page 1
Antitumor Immunity Is Controlled by Tetraspanin Proteins.
Schaper F, van Spriel AB. Schaper F, et al. Front Immunol. 2018 May 29;9:1185. doi: 10.3389/fimmu.2018.01185. eCollection 2018. Front Immunol. 2018. PMID: 29896201 Free PMC article. Review.
MAGE-A antigens as targets for cancer immunotherapy.
Schooten E, Di Maggio A, van Bergen En Henegouwen PMP, Kijanka MM. Schooten E, et al. Cancer Treat Rev. 2018 Jun;67:54-62. doi: 10.1016/j.ctrv.2018.04.009. Epub 2018 Apr 26. Cancer Treat Rev. 2018. PMID: 29763778 Review.
Melanoma antigens and related immunological markers.
Pitcovski J, Shahar E, Aizenshtein E, Gorodetsky R. Pitcovski J, et al. Crit Rev Oncol Hematol. 2017 Jul;115:36-49. doi: 10.1016/j.critrevonc.2017.05.001. Epub 2017 May 6. Crit Rev Oncol Hematol. 2017. PMID: 28602168 Review.
Role of immunotherapy in bladder cancer: past, present and future.
Butt SU, Malik L. Butt SU, et al. Cancer Chemother Pharmacol. 2018 Apr;81(4):629-645. doi: 10.1007/s00280-018-3518-7. Epub 2018 Jan 24. Cancer Chemother Pharmacol. 2018. PMID: 29368051 Review.
Genome-wide CRISPR screen identifies FAM49B as a key regulator of actin dynamics and T cell activation.
Shang W, Jiang Y, Boettcher M, Ding K, Mollenauer M, Liu Z, Wen X, Liu C, Hao P, Zhao S, McManus MT, Wei L, Weiss A, Wang H. Shang W, et al. Proc Natl Acad Sci U S A. 2018 Apr 24;115(17):E4051-E4060. doi: 10.1073/pnas.1801340115. Epub 2018 Apr 9. Proc Natl Acad Sci U S A. 2018. PMID: 29632189 Free PMC article.
Mucosal HPV E6/E7 Peptide Vaccination in Combination with Immune Checkpoint Modulation Induces Regression of HPV+ Oral Cancers.
Dorta-Estremera S, Chin RL, Sierra G, Nicholas C, Yanamandra AV, Nookala SMK, Yang G, Singh S, Curran MA, Sastry KJ. Dorta-Estremera S, et al. Cancer Res. 2018 Sep 15;78(18):5327-5339. doi: 10.1158/0008-5472.CAN-18-0892. Epub 2018 Jul 27. Cancer Res. 2018. PMID: 30054333 Free PMC article.
Antibody Therapies in Cancer.
Wang S, Jia M. Wang S, et al. Adv Exp Med Biol. 2016;909:1-67. doi: 10.1007/978-94-017-7555-7_1. Adv Exp Med Biol. 2016. PMID: 27240456 Review.
Dual-specific Chimeric Antigen Receptor T Cells and an Indirect Vaccine Eradicate a Variety of Large Solid Tumors in an Immunocompetent, Self-antigen Setting.
Slaney CY, von Scheidt B, Davenport AJ, Beavis PA, Westwood JA, Mardiana S, Tscharke DC, Ellis S, Prince HM, Trapani JA, Johnstone RW, Smyth MJ, Teng MW, Ali A, Yu Z, Rosenberg SA, Restifo NP, Neeson P, Darcy PK, Kershaw MH. Slaney CY, et al. Clin Cancer Res. 2017 May 15;23(10):2478-2490. doi: 10.1158/1078-0432.CCR-16-1860. Epub 2016 Dec 13. Clin Cancer Res. 2017. PMID: 27965307 Free PMC article.
6,711 results
Jump to page
Feedback